• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Estrella Immunopharma, Inc. - Common Stock (NQ:ESLA)

    0.9100 -0.1100 (-10.78%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Jul 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 37,711
    Open 1.020
    Bid (Size) 0.9100 (1,700)
    Ask (Size) 1.090 (100)
    Prev. Close 1.020
    Today's Range 0.9100 - 1.021
    52wk Range 0.7800 - 3.150
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Estrella Immunopharma to Participate in the D. Boral Capital Global Conference
    From Estrella Immunopharma, Inc.
    Via Business Wire
    Which stocks are moving on Monday? ↗
    Via Chartmill

    Performance

    YTD
    -34.5%
    -34.5%
    1 Month
    -19.5%
    -19.5%
    3 Month
    -33.1%
    -33.1%
    6 Month
    -31.6%
    -31.6%
    1 Year
    +3.2%
    +3.2%

    More News

    Read More
    News headline image
    Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
    From Estrella Immunopharma, Inc.
    Via Business Wire
    Monday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR®
    From Estrella Immunopharma, Inc.
    Via Business Wire
    Curious about the stocks that are showing activity after the closing bell on Friday? ↗
    Via Chartmill
    Here are the top movers in Thursday's session. ↗
    Via Chartmill
    Thursday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB103 at the 2026 Tandem Meetings of ASTCT® & CIBMTR®
    From Estrella Immunopharma, Inc.
    Via Business Wire
    BioMedNewsBreaks – Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) Closes $8.0 Million Registered Direct Offering
    Via Investor Brand Network
    News headline image
    Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement
    From Estrella Immunopharma, Inc.
    Via Business Wire
    News headline image
    Estrella Immunopharma, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
    From Estrella Immunopharma, Inc.
    Via Business Wire
    News headline image
    Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation
    From Estrella Immunopharma, Inc.
    Via Business Wire
    News headline image
    Tuesday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Which stocks are moving on Monday? ↗
    Via Chartmill
    News headline image
    Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients
    From Estrella Immunopharma, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Estrella Immunopharma Regains Compliance with Nasdaq Listing Requirements
    From Estrella Immunopharma, Inc.
    Via Business Wire
    News headline image
    Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
    From Estrella Immunopharma, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Estrella Immunopharma Announces Approximately $3.35 Million Private Placement Equity Financing
    From Estrella Immunopharma, Inc.
    Via Business Wire
    News headline image
    Estrella Immunopharma Initiates Second Cohort and Doses First Patient in STARLIGHT-1 Trial of EB103 in Advanced B-Cell Non-Hodgkin’s Lymphomas
    From Estrella Immunopharma, Inc.
    Via Business Wire
    News headline image
    Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Buy Rating With a Price Target of $14.00 From CB Capital Partners
    From Estrella Immunopharma, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Estrella Immunopharma, Inc. - Common Stock publicly traded?
    Yes, Estrella Immunopharma, Inc. - Common Stock is publicly traded.
    What exchange does Estrella Immunopharma, Inc. - Common Stock trade on?
    Estrella Immunopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Estrella Immunopharma, Inc. - Common Stock?
    The ticker symbol for Estrella Immunopharma, Inc. - Common Stock is ESLA on the Nasdaq Stock Market
    What is the current price of Estrella Immunopharma, Inc. - Common Stock?
    The current price of Estrella Immunopharma, Inc. - Common Stock is 0.9100
    When was Estrella Immunopharma, Inc. - Common Stock last traded?
    The last trade of Estrella Immunopharma, Inc. - Common Stock was at 07/07/26 03:59 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.